Effect of Displacement on Adherence to TB Treatment: An Observational Study in TB Patients from Internally Displaced Persons of Pakistan.
Adherence
Displacement
Internally Displaced Persons
TB Treatment Outcomes
Tuberculosis
Journal
Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117
Informations de publication
Date de publication:
Historique:
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
6
2021
Statut:
ppublish
Résumé
This study was aimed to investigate TB patients adherence and treatment outcomes among internally displaced patients in comparison with adjacent settled areas. The study was designed as an observational cross-sectional study among the TB patients of internally displaced populations (IDPs) of North Waziristan Agency (NWA) and adjacent settled areas of Bannu and Lakki Marwat (NIDPs). Based on the study inclusion and exclusion criteria 330 patients fullfilled the inclusion criteria and were assigned equally to both IDPs and NIDPs study groups. Odds ratio (OR) with 95% confidence interval was calculated and p-values, 0.05 were considered statistically significant. The treatment outcomes with the status of "cured" and "completed treatment" were better among NIDPs as compared to IDPs. Patients with treatment outcome status of "defaulted treatment", "without documentary evidence, and "failure" were high in IDPs as compared to NIDPs. Adherence to TB treatment was better among NIDPs (50.9%) as compared to IDPs (39.4%). The patients showing non-adherence to TB treatment were more among IDPS (27.3%) than NIDPs (10.9%). Overall results of this study revealed a poor adherence to the TB treatment medications with an odds ratio of 0.286, (p<0.05) among IDPs as compared with NIDPs.
Identifiants
pubmed: 34104146
doi: 10.12669/pjms.37.3.2992
pii: PJMS-37-675
pmc: PMC8155409
doi:
Types de publication
Journal Article
Langues
eng
Pagination
675-679Informations de copyright
Copyright: © Pakistan Journal of Medical Sciences.
Références
J Pak Med Assoc. 2016 Aug;66(8):989-93
pubmed: 27524534
Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):581-6
pubmed: 21174222
BMC Public Health. 2015 May 08;15:474
pubmed: 25952360
PLoS One. 2013 Dec 05;8(12):e82440
pubmed: 24349284
Tuberc Res Treat. 2014;2014:726193
pubmed: 24891948
Lancet Infect Dis. 2012 Dec;12(12):950-65
pubmed: 23174381
Health Promot Perspect. 2020 Jan 28;10(1):24-37
pubmed: 32104654
PLoS Pathog. 2018 Jun 7;14(6):e1007014
pubmed: 29879218
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):610-623
pubmed: 28482955
Pak J Med Sci. 2020 Jan;36(1):S49-S54
pubmed: 31933607
PLoS One. 2012;7(12):e52334
pubmed: 23284993
Pak J Med Sci. 2020 Jan-Feb;36(2):198-202
pubmed: 32063959
Confl Health. 2015 May 18;9:18
pubmed: 26078784
PLoS One. 2012;7(3):e32140
pubmed: 22427820
Int J Tuberc Lung Dis. 2010 Aug;14(8):973-9
pubmed: 20626941
Indian J Tuberc. 2020 Jan;67(1):87-93
pubmed: 32192624